Adolescent gynecology

Obstetrics and Gynecology

Volumn 113, Issue 4, 2009, Pages 935-947

  Sanfilippo, Joseph S ^a,c   Lara Torre, Eduardo ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CARILION CLINIC   (United States)

^c Department of Ob Gyn and Reproductive Sciences ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIANDROGEN; CLOMIFENE CITRATE; DANAZOL; DESOGESTREL; ETHINYLESTRADIOL; GLUCOCORTICOID; GONADORELIN AGONIST; GOSERELIN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; METFORMIN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE DERIVATIVE; SPERMICIDAL AGENT; SPIRONOLACTONE; WART VIRUS VACCINE;

ADOLESCENT; ADOLESCENT HEALTH; ANDROGEN DEFICIENCY; ANOVULATION; BLEEDING; BONE DENSITY; CLINICAL TRIAL; CONDOM; CONDYLOMA ACUMINATUM; CONTRACEPTION; COUNSELING; DIABETES MELLITUS; DIAGNOSTIC TEST; EATING DISORDER; ENDOMETRIOSIS; FEMALE INFERTILITY; GYNECOLOGIC DISEASE; HIRSUTISM; HISTOPATHOLOGY; HUMAN; INSULIN RESISTANCE; INTRAUTERINE CONTRACEPTIVE DEVICE; LAPAROSCOPIC SURGERY; MENSTRUATION DISORDER; OVARY POLYCYSTIC DISEASE; PATIENT COMPLIANCE; PELVIS PAIN SYNDROME; PRACTICE GUIDELINE; PREGNANCY RATE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PUBERTY; REPRODUCTIVE HEALTH; REVIEW; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; SYSTEMATIC REVIEW; UTERINE CERVIX CAP; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; UTERUS BLEEDING; VAGINA BLEEDING; VIOLENCE; WART VIRUS; WEIGHT GAIN; ADOLESCENT PREGNANCY; CHILD PSYCHOLOGY; FEMALE; GYNECOLOGY; MEDICINE; MENSTRUATION; METHODOLOGY; PATIENT EDUCATION; PHYSIOLOGY; PREGNANCY; PSYCHOLOGICAL ASPECT; STANDARD;

ADOLESCENT; ADOLESCENT MEDICINE; ADOLESCENT PSYCHOLOGY; CONTRACEPTION; EATING DISORDERS; ENDOMETRIOSIS; FEMALE; GYNECOLOGY; HUMANS; MENSTRUATION; MENSTRUATION DISTURBANCES; PAPILLOMAVIRUS VACCINES; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY IN ADOLESCENCE; PUBERTY; SEXUALLY TRANSMITTED DISEASES;

EID: 65649101252     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31819b6303     Document Type: Review

References (57)

1. American College of Obstetricians and Gynecologists. A guideline for women's health care. 2nd ed. Washington, D.C.: ACOG; 2002.
2. American College of Obstetricians and Gynecologists. Toolkit for teen care. Washington, D.C.: ACOG; 2003.
3. American College of Obstetricians and Gynecologists. Primary and Preventive Care: periodic assessments. ACOG Committee Opinion. Obstet Gynecol 2003;102:1117-24.
4. Evaluation and management of abnormal cervical cytology and histology in the adolescent. ACOG Committee Opinion No. 330. American College of Obstetricians and Gynecologists. Obstet Gynecol 2006;107:963-8.
5. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007;197:346-55.
6. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007;197: 340-5.
7. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004;364:1757-65.
8. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8.
9. Rimsza M. Dysfunctional uterine bleeding. Pediatr Rev 2002; 23:227-33.
10. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. ACOG Committee Opinion No. 349. American College of Obstetricians and Gynecologists. Obstet Gynecol 2006;108:1323-8.
11. Matytsina LA, Zoloto EV, Sinenko LV, Greydanus D. Dysfunctional uterine bleeding in adolescents: concepts of pathophysiology and management. Prim Care 2006;33:503-15.
12. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181-91.
13. Kent SC, Legro RS. Polycystic ovary syndrome in adolescents. Adolesc Med 2002;13:73-88.
14. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovarian syndrome. Fertil Steril 2004;81:19-25.
15. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91:4237-45.
16. Ibanez L, Dimartino-Nardi J, Potau N, Saenger P. Premature adrenarche-normal variant or forerunner of adult disease? Endocr Rev 2000;21:671-96.
17. Ibanez L, Potau N, Francois I, de Zegher F. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998;83:3558-62.
18. Fleischman A, Mansfield J. Diagnosis and treatment of polycystic ovarian syndrome and insulin resistance. Pediatr Ann 2005;34:733-42.
19. Pastor CL, Griffin-Korf ML, Aloi JA, Evans WS, Marshall JC. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 1998;83:582-90.
20. Nelson VL, Qin KN, Rosenfield RL, Wood JR, Penning TM, Legro RS, et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86: 5925-33.
21. Amato P, Simpson JL. The genetics of polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:707-18.
22. Franks S, Gharani N, Waterworth D, Batty S, White D, Williamson R, et al. Genetics of polycystic ovary syndrome. Mol Cell Endocrinol 1998;145:123-8.
23. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;24:1440-7.
24. Buggs C, Rosenfield RL. Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am 2005;34:677-705.
25. Darroch JE, Singh S, Frost JJ. Differences in teenage pregnancy rates among five developed countries: the roles of sexual activity and contraceptive use [published erratum appears in Fam Plann Perspect 2002;34:56]. Fam Plann Perspect 2001;33: 244-50.
26. Smith CA. Factors associated with early sexual activity among urban adolescents. Soc Work 1997;42:334-46.
27. Eaton DK, Kann L, Kinchen S, Shanklin S, Ross J, Hawkins J, et al. Youth risk behavior surveillance- United States 2007. MMWR Surveill Summ 2008;57 (SS-4):1-131.
28. Thomas MH. Abstinence-based programs for prevention of adolescent pregnancies. A review. J Adolesc Health 2000;26: 5-17.
29. Hewitt G, Cromer B. Update on adolescent contraception. Obstet Gynecol Clin North Am 2000;27:143-62.
30. Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive [published erratum appears in Contraception 2004;69:175]. Contraception 2003;68:89-96.
31. Lara-Torre E, Schroeder B. Adolescent compliance and side effects with Quick Start initiation of oral contraceptive pills. Contraception 2002;66:81-5.
32. U.S. Food and Drug Administration. FDA updates labeling for Ortho Evra contraceptive patch 2005. Available at: http:// www.fda.gov/bbs/topics/news/ 2005/NEW01262.html. Retrieved January 16, 2009.
33. Graham S, Fraser IS. The progestogen-only mini-pill. Contraception 1982;26:373-88.
34. Le J, Tsourounis C. Implanon: a critical review. Ann Pharmacother 2001;35:329-36.
35. Cheng L, Gulmezoglu AM, Oel CJ, Piaggio G, Ezcurra E, Look PF. Interventions for emergency contraception. The Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD001324. DOI: 10.1002/14651858.CD001324.
36. Belzer M, Yoshida E, Tejirian T, Tucker D, Chung K, Sanchez K.. Advanced supply of emergency contraception for adolescent mothers increased utilization without reducing condom or primary contraception use. J Adolesc Health 2003;32:122-23.
37. Stuart GS, Castano PM. Sexually transmitted infections and contraceptives: selective issues. Obstet Gynecol Clin North Am 2003;30:795-808.
38. Grimes DA, Schulz KF. Prophylactic antibiotics for intrauterine device insertion: a metaanalysis of the randomized controlled trials. Contraception 1999;60:57-63.
39. Intrauterine device and adolescents. ACOG Committee Opinion No. 392. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;110:1493-5.
40. von Rokitansky C. Uberusdausen-neubuildung in uterus and ovarian sarcoma. Ztschrdkk Gesellsch Aertweinezu 1860;37: 577.
41. Sampson J. Perforating hemorrhagic (Chocolate) cysts of the ovary Arch Surg 1921;3: 245-323.
42. Fallon J. Endometriosis in youth JAMA 1946;131:1405-6.
43. Bontis JN, Vavilis DT. Etiopathology of endometriosis Ann NY Acad Sci 1997;817:305-9.
44. Reese KA, Reddy S, Rock JA. Endometriosis in an adolescent population: the Emory experience. J Pediatr Adolesc Gynecol 1996;9:125-8.
45. Marsh EE, Laufer MR. Endometriosis in premenarcheal girls who do not have an associated obstructive anomaly Fertil Steril 2005;83:758-60.
46. Yamamoto K, Mitsuhashi Y, Takaike T, Takase K, Hoshiai H, Noda K. Tubal endometriosis diagnosed within one month after menarche: a case report. Tohoko J Exp Med 1997;181: 385-7.
47. Laufer M, Sanfilippo J, Rose G. Adolescent Endometriosis: diagnosis and treatment approaches J Pediatr Adolesc Gynecol 2003;16:S3-11.
48. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril 1985;43:351-2.
49. Schifrin BS, Erez S, Moore JG. Teen-age endometriosis. Am J Obstet Gynecol 1973;116:973-80.
50. Goldstein DP, deCholnoky C, Leventhal JM, Emans SJ. New insights into the old problem of chronic pelvic pain. J Pediatr Surg 1979;14:675-80.
51. Sanfilippo JS, Wakim NG, Schikler KN, Yussman MA. Endometriosis in association with uterine anomaly Am J Obstet Gynecol 1986;154:39-43.
52. Gao X, Yeh YC, Outley J, Simon J, Botteman M, Spalding J. Health-related quality of life burden of women with endometriosis: a literature review. Curr Med Res Opin 2006;22: 1787-97.
53. Laufer MR, Goitein L, Bush M, Cramer DW, Emans SJ. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr Adolesc Gynecol 1997;10:199-202.
54. Endometriosis in adolescents. ACOG Committee Opinion No. 310. American College of Obstetricians and Gynecologists. Obstet Gynecol 2005;105:921-7.
55. Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin-releasing hormone agonist vs. a low-dose oral contraceptive for pelvic pain associated with endometriosis Fertil Steril 1993;60:75-9.
56. Vercellini P, De Georgio O, Aimi G, Panazza S, Uglietti A, Crosignani PG. Menstrual characteristics in women with and without endometriosis Obstet Gynecol 1997;90:264-8.
57. Moghissi K. Medical treatment of endometriosis, Clin Obstet Gynecol 1999;42:620-32.